Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations
- PMID: 18486172
- DOI: 10.1016/j.trstmh.2008.04.005
Impact of pooling on accuracy of hepatitis B virus surface antigen screening of blood donations
Abstract
Expenditure on screening blood donations in developing countries can be reduced by testing donations in pools. This study evaluated serological screening in pools for hepatitis B virus (HBV) at the Israeli national blood bank and a hospital blood bank in Gaza, the Palestinian Authority. The accuracy of HBV surface antigen (HBsAg) enzyme immunoassay performed on pools of 3-24 samples was compared with individual tests. Delay in detecting positive samples due to dilution in pools and the possibility of antibody-antigen neutralization were analyzed. The sensitivity of pooled testing for HBsAg was 93-99%, prolonging the window period by 5 days (8.3%). Neutralization of HBsAg by hepatitis B surface antibodies (anti-HBs) could be minimized by testing immediately after pooling. Serological testing for HBsAg in pools may be performed using manually created pools of up to six samples, with 5% loss in sensitivity and a risk of neutralization by anti-HBs present in the donor population. Pooling can therefore be considered as an option only in countries with a low prevalence of HBV.
Similar articles
-
Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?Transfus Clin Biol. 2004 Feb;11(1):26-32. doi: 10.1016/j.tracli.2003.12.003. Transfus Clin Biol. 2004. PMID: 14980546 Review.
-
Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.Transfusion. 2007 Oct;47(10):1809-15. doi: 10.1111/j.1537-2995.2007.01396.x. Transfusion. 2007. PMID: 17880605
-
Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.Transfusion. 2006 Dec;46(12):2047-52. doi: 10.1111/j.1537-2995.2006.01031.x. Transfusion. 2006. PMID: 17176315
-
Donor screening for hepatitis B virus infection in a cell and tissue bank.Transpl Infect Dis. 2008 Dec;10(6):391-5. doi: 10.1111/j.1399-3062.2008.00331.x. Epub 2008 Jul 28. Transpl Infect Dis. 2008. PMID: 18665905
-
Hepatitis B virus blood screening: unfinished agendas.Vox Sang. 2006 Jul;91(1):1-12. doi: 10.1111/j.1423-0410.2006.00773.x. Vox Sang. 2006. PMID: 16756595 Review.
Cited by
-
Development of a sensitive enzyme-linked immunosorbent assay for detection of hepatitis B surface antigen using novel monoclonal antibodies.Avicenna J Med Biotechnol. 2010 Oct;2(4):207-14. Avicenna J Med Biotechnol. 2010. PMID: 23408744 Free PMC article.
-
Improvement of Sensitivity of Pooling Strategies for COVID-19.Comput Math Methods Med. 2021 Oct 13;2021:6636396. doi: 10.1155/2021/6636396. eCollection 2021. Comput Math Methods Med. 2021. PMID: 34691239 Free PMC article.
-
Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B.Haematologica. 2016 Jul;101(7):e303-5. doi: 10.3324/haematol.2016.144840. Epub 2016 Apr 21. Haematologica. 2016. PMID: 27102500 Free PMC article. No abstract available.
-
Proposal of RT-PCR-Based Mass Population Screening for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019).J Mol Diagn. 2020 Oct;22(10):1294-1299. doi: 10.1016/j.jmoldx.2020.07.001. Epub 2020 Jul 30. J Mol Diagn. 2020. PMID: 32738298 Free PMC article.
-
Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians.PLoS One. 2017 Feb 14;12(2):e0171709. doi: 10.1371/journal.pone.0171709. eCollection 2017. PLoS One. 2017. PMID: 28196110 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical